AddLife completes the acquisition of Telia Health Monitoring

AddLife has today completed the previously announced acquisition of Telia Health Monitoring that develops and provides a digital platform solution that enables self-monitoring by patients with chronic diseases such as heart disease, hypertension, COPD, diabetes and IBD. The business, with sales of SEK 4m and its seven employees, will be integrated into Camanio and become part of business area Medtech. By combining the digital care platform from Camanio with Telia’s Health Monitoring solution there are great opportunities to support care providers in the development of digital care.

Stockholm 1 March 2022
AddLife AB (publ)

For further information, please contact:
Martin Almgren, Affärsområdeschef Medtech och CFO, AddLife AB, +46 (0)702 28 15 45
Kristina Willgård, VD, AddLife AB, +46 (0)705 10 12 23

AddLife is an independent European player in Life Science that offers high-quality products, services and consulting to both the private and public sectors. AddLife has about 2,200 employees in around 80 operating subsidiaries, which operate under their own brands. The Group has annual sales of approximately SEK 8 billion. AddLife is listed on the NASDAQ Stockholm stock exchange.

This information was issued for publication on 1 March 2022 at 11:45 CET.